Exon 20 YVMA insertion is associated with high incidence of brain metastasis and inferior outcome of chemotherapy in advanced non-small cell lung cancer patients with HER2 kinase domain mutations-Reference-Cited by-同舟云学术

Exon 20 YVMA insertion is associated with high incidence of brain metastasis and inferior outcome of chemotherapy in advanced non-small cell lung cancer patients with HER2 kinase domain mutations

Published:2021-02 Issue:2 Volume:10 Page:753-765
ISSN:2218-6751
Container-title:Translational Lung Cancer Research
language:
Short-container-title:Transl Lung Cancer Res

Author:

Yang Shuo,Wang Yan,Zhao Chao,Li Xuefei,Liu Qian,Mao Shiqi,Liu Yiwei,Yu Xiaofei,Wang Wanying,Tian Qinrun,Pan Yingying,Xiong Anwen,Chen Bin,Gao Guanghui,Li Wei,He Yayi,Wu Fengying,Chen Xiaoxia,Su Chunxia,Ren Shengxiang,Zhou Caicun

Publisher

AME Publishing Company

Subject

Oncology

Link

https://tlcr.amegroups.com/article/download/49582/pdf

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and treatment of human epidermal growth factor receptor 2-altered non-small cell lung cancer: a retrospective analysis and systematic literature review;ecancermedicalscience;2024-08-01

2. Clinical and structural insights into the rare but oncogenic HER2-activating missense mutations in non-small cell lung cancer: a retrospective ATLAS cohort study;Discover Oncology;2024-07-16

3. Spotlight on the treatment of non‐small cell lung cancer with rare genetic alterations and brain metastasis: Current status and future perspectives;International Journal of Cancer;2024-07-03

4. The rapidly changing field of predictive biomarkers of non-small cell lung cancer;Pathology and Oncology Research;2024-06-17

5. Clinical characteristics and association with immunotherapy outcomes in SMARCA4-deficient NSCLC;2024-06-13